Stockpolly
Search
Delisting risk
NSPR · NASDAQ · Medical - Devices

InspireMD (NSPR)

Develops CGuard mesh-covered carotid stents for stroke prevention.

$0.9132
Pre-market+0.04 (+5.04%)
At close$0.8694(−4.30%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue222222223332
Cost of revenue111111112233
Gross profit01000000111−1
6689910121314131514
Research & development223344444354
445556891010109
Selling & marketing111112344555
General & administrative334434556554
Operating income−6−6−7−8−8−9−11−13−13−12−14−14
0000100000140
Interest income000010000000
Interest expense000000000000
Other non-operating income0000−100000−140
Income before tax−5−5−7−8−8−9−11−13−13−120−14
Income tax expense000000000000
Net income from continuing operations−5−5−7−8−8−9−11−13−13−120−14
Net income−5−5−7−8−8−9−11−13−13−120−14
EPS, basic−$0.15−$0.25−$0.21−$0.22−$0.16−$0.19−$0.22−$0.26−$0.17−$0.14$0.00−$0.19
EPS, diluted−$0.15−$0.25−$0.21−$0.22−$0.16−$0.19−$0.22−$0.26−$0.17−$0.14$0.00−$0.19
Weighted average shares, basic342234364849505173737373
Weighted average shares, diluted342234364849505173737373
EBITDA−6−5−7−8−8−9−11−13−13−120−14
Depreciation & amortization000000000000
EBIT−6−5−7−8−8−9−11−13−13−120−14